secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001493152-23-024951
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Biostage annual meeting: all four proposals pass, equity plan amended
---------------------------------------------------------------------

- Junli He and James Shmerling elected as Class I directors; He received 10,377,115 'for' votes, Shmerling 2,345,415 'for' with 8,041,390 withheld.
- Ratification of Marcum LLP as auditor for FY2023 approved: 11,763,540 for, 5,174 against, 473 abstentions.
- Amendment to Amended and Restated Equity Incentive Plan to increase share reserve by 4,000,000 shares approved: 10,370,321 for, 16,358 against, 126 abstentions.
- Non-binding advisory vote on executive compensation approved: 10,184,823 for, 12,603 against, 189,379 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000149315223024951/0001493152-23-024951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000149315223024951/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer